Back to Search
SARA MELOCHE, MD
MD
Internal Medicine Physician
NPI: 1689724981IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
H8254(TX)
CMS Specialties
PrimaryINTERNAL MEDICINE
Education
UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON
Class of 1989
Research & Publications (20)
Effects of angiotensin-converting enzyme inhibitor versus valsartan on cellular signaling events in heart transplant.
PMID 19417110·Ann Pharmacother·2009
2-rct
Artifactual sulfation of silver-stained proteins: implications for the assignment of phosphorylation and sulfation sites.
PMID 18936056·Mol Cell Proteomics·2009
7-preclinical
ER stress affects processing of MHC class I-associated peptides.
PMID 19220912·BMC Immunol·2009
7-preclinical
Interpreting neonatal lethal phenotypes in mouse mutants: insights into gene function and human diseases.
PMID 19126753·Physiol Rev·2009
6-review
Activation loop phosphorylation of the atypical MAP kinases ERK3 and ERK4 is required for binding, activation and cytoplasmic relocalization of MK5.
PMID 18720373·J Cell Physiol·2008
7-preclinical
Activation of MEK1 or MEK2 isoform is sufficient to fully transform intestinal epithelial cells and induce the formation of metastatic tumors.
PMID 19014680·BMC Cancer·2008
7-preclinical
Phosphorylation of IRF-3 on Ser 339 generates a hyperactive form of IRF-3 through regulation of dimerization and CBP association.
PMID 18272581·J Virol·2008
7-preclinical
The eIF4E RNA regulon promotes the Akt signaling pathway.
PMID 18391071·J Cell Biol·2008
7-preclinical
Phosphorylation of Skp2 regulated by CDK2 and Cdc14B protects it from degradation by APC(Cdh1) in G1 phase.
PMID 18239684·EMBO J·2008
7-preclinical
The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition.
PMID 17496918·Oncogene·2007
6-review
Sustained in vitro trigger of self-renewal divisions in Hoxb4hiPbx1(10) hematopoietic stem cells.
PMID 17577929·Exp Hematol·2007
7-preclinical
FGF stimulation of the Erk1/2 signalling cascade triggers transition of pluripotent embryonic stem cells from self-renewal to lineage commitment.
PMID 17660198·Development·2007
7-preclinical
Atypical mitogen-activated protein kinases: structure, regulation and functions.
PMID 17161475·Biochim Biophys Acta·2007
6-review
Genetic inhibition of cardiac ERK1/2 promotes stress-induced apoptosis and heart failure but has no effect on hypertrophy in vivo.
PMID 17709754·Proc Natl Acad Sci U S A·2007
7-preclinical
Involvement of the IkappaB kinase (IKK)-related kinases tank-binding kinase 1/IKKi and cullin-based ubiquitin ligases in IFN regulatory factor-3 degradation.
PMID 17015689·J Immunol·2006
7-preclinical
E4F1: a novel candidate factor for mediating BMI1 function in primitive hematopoietic cells.
PMID 16882984·Genes Dev·2006
7-preclinical
Regulation of MAPK-activated protein kinase 5 activity and subcellular localization by the atypical MAPK ERK4/MAPK4.
PMID 16971392·J Biol Chem·2006
8-other
Cyclic AMP induces morphological changes of vascular smooth muscle cells by inhibiting a Rac-dependent signaling pathway.
PMID 15706595·J Cell Physiol·2005
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1010 S PONDS DR
WEBSTER, TX 77598 - Phone
- (713) 442-4300
Quick Facts
- NPI
- 1689724981
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 37
- Publications
- 20
Are you this provider?
Claim Your Profile